drugset / Trial / NCT04134715
A Drug Drug Interaction Study Between PF-06826647 And Oral Contraceptive Steroids In Healthy Female Participants
SequentialOpen-labelOther
Summary
This is a Phase 1, fixed sequence, multiple dose, open label study of the effect of PF-06826647 on oral contraceptive (OC) pharmacokinetics (PK) and vice versa in healthy female participants. A total of approximately 15 healthy female participants will be enrolled and dosed to achieve at least 12 participants completing the study.
Timeline
- Start
- 2019-10-23
- Primary completion
- 2020-01-09
- Completion
- 2020-01-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EE | Unknown | 30 ug | Oral |
| Subject | LN | Unknown | 150 ug | Oral |
| Subject | ROPSACITINIB | Small molecule | 600 mg | — |
Indications
No indication recorded.